<DOC>
	<DOCNO>NCT00880178</DOCNO>
	<brief_summary>Coronary heart disease ( CHD ) serious health concern affect million people United States . It usually cause atherosclerosisâ€”a condition occur fatty material plaque build wall artery supply blood oxygen heart , cause artery narrow . As artery narrow , blood flow heart slow stop , cause chest pain , shortness breath , heart attack , heart failure . Another component CHD event involve inflammatory change result structural breakdown atherosclerotic plaque . Adding niacin statin medication may effective way block inflammation atherosclerotic plaque . This study examine magnetic resonance imaging ( MRI ) image blood sample participant AIM-HIGH study take niacin plus statins statin alone determine effect medication inflammation atherosclerotic plaque .</brief_summary>
	<brief_title>Plaque Inflammation Dysfunctional HDL Cholesterol Participants Receiving Niacin Statins AIM-HIGH Study ( The HDL Proteomics Study )</brief_title>
	<detailed_description>CHD lead cause death United States . Preliminary research show CHD associate oxidative inflammatory change high-density lipoprotein ( HDL ) cholesterol , consider `` good '' cholesterol . The inflammatory change impair HDL cholesterol 's normal function , remove excess cholesterol artery thereby slow build-up atherosclerotic plaque . Statins cholesterol-lowering medication use treat people CHD . Taking niacin , type B vitamin , combination statin may stabilize atherosclerotic plaque well statin alone , research need examine niacin may . By improve ability HDL cholesterol repair inflammatory damage atherosclerotic plaque , niacin may assist prevent inflammation lead plaque breakdown . The AIM-HIGH study ( NCT00120289 ) examine use niacin plus statins people vascular disease . Participants AIM-HIGH study randomly assign receive either niacin plus simvastain , type statin medication , simvastain alone . The purpose substudy determine whether niacin combination statin reduce atherosclerotic plaque inflammation dysfunctional HDL cholesterol statins alone . The substudy enroll participant participate AIM-HIGH study . At AIM-HIGH baseline Year 2 study visit , study researcher substudy collect additional blood sample participant examine change HDL oxidation level protein composition time point . Study researcher also analyze participant ' MRI scan examine change plaque inflammation study period ; MRI scan complete part another AIM-HIGH substudy , conduct Dr. Xue-Qiao Zhao . There additional study procedure visit participant substudy .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Niacin</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Eligible main AIMHIGH study ( NCT00120289 ) Willing provide inform consent participation substudy</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Simvastatin</keyword>
	<keyword>Niacin</keyword>
	<keyword>Vascular Disease</keyword>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>High Density Lipoprotein</keyword>
	<keyword>Oxidation</keyword>
	<keyword>Proteomics</keyword>
	<keyword>Stroke</keyword>
	<keyword>Cerebrovascular Accident</keyword>
</DOC>